129 related articles for article (PubMed ID: 34194624)
1. TERT and its binding protein: overexpression of GABPA/B in high grade gliomas.
Papazacharias E; Kuhl S; Röhn G; Görtz L; Goldbrunner R; Timmer M
Oncotarget; 2021 Jun; 12(13):1271-1280. PubMed ID: 34194624
[TBL] [Abstract][Full Text] [Related]
2. TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends.
Yuan X; Dai M; Xu D
Cancer Lett; 2020 Nov; 493():1-9. PubMed ID: 32768523
[TBL] [Abstract][Full Text] [Related]
3. Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features.
Xing X; Mu N; Yuan X; Wang N; Juhlin CC; Strååt K; Larsson C; Neo SY; Xu D
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326537
[TBL] [Abstract][Full Text] [Related]
4. GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Guo Y; Yuan X; Li K; Dai M; Zhang L; Wu Y; Sun C; Chen Y; Cheng G; Liu C; Strååt K; Kong F; Zhao S; Bjorkhölm M; Xu D
Cell Death Differ; 2020 Jun; 27(6):1862-1877. PubMed ID: 31802036
[TBL] [Abstract][Full Text] [Related]
5. TERT promoter mutations in primary and secondary glioblastomas.
Nonoguchi N; Ohta T; Oh JE; Kim YH; Kleihues P; Ohgaki H
Acta Neuropathol; 2013 Dec; 126(6):931-7. PubMed ID: 23955565
[TBL] [Abstract][Full Text] [Related]
6. Hyperpolarized δ-[1-
Minami N; Hong D; Taglang C; Batsios G; Gillespie AM; Viswanath P; Stevers N; Barger CJ; Costello JF; Ronen SM
Sci Rep; 2023 Mar; 13(1):5190. PubMed ID: 36997627
[TBL] [Abstract][Full Text] [Related]
7. Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Liu R; Zhang T; Zhu G; Xing M
Nat Commun; 2018 Feb; 9(1):579. PubMed ID: 29422527
[TBL] [Abstract][Full Text] [Related]
8.
Zhang T; Xu M; Makowski MM; Lee C; Kovacs M; Fang J; Willems E; Trent JM; Hayward NK; Vermeulen M; Brown KM
Cancer Res; 2017 Apr; 77(7):1649-1661. PubMed ID: 28108517
[No Abstract] [Full Text] [Related]
9. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Yuan X; Mu N; Wang N; Strååt K; Sofiadis A; Guo Y; Stenman A; Li K; Cheng G; Zhang L; Kong F; Ekblad L; Wennerberg J; Nilsson IL; Juhlin CC; Larsson C; Xu D
Oncogene; 2019 Feb; 38(7):965-979. PubMed ID: 30181547
[TBL] [Abstract][Full Text] [Related]
10. The heteromeric transcription factor GABP activates the ITGAM/CD11b promoter and induces myeloid differentiation.
Ripperger T; Manukjan G; Meyer J; Wolter S; Schambach A; Bohne J; Modlich U; Li Z; Skawran B; Schlegelberger B; Steinemann D
Biochim Biophys Acta; 2015 Sep; 1849(9):1145-54. PubMed ID: 26170143
[TBL] [Abstract][Full Text] [Related]
11. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss.
Arita H; Narita Y; Fukushima S; Tateishi K; Matsushita Y; Yoshida A; Miyakita Y; Ohno M; Collins VP; Kawahara N; Shibui S; Ichimura K
Acta Neuropathol; 2013 Aug; 126(2):267-76. PubMed ID: 23764841
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds.
You H; Wu Y; Chang K; Shi X; Chen XD; Yan W; Li R
CNS Neurosci Ther; 2017 Oct; 23(10):790-797. PubMed ID: 28868656
[TBL] [Abstract][Full Text] [Related]
13. TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Gao K; Li G; Qu Y; Wang M; Cui B; Ji M; Shi B; Hou P
Oncotarget; 2016 Feb; 7(8):8712-25. PubMed ID: 26556853
[TBL] [Abstract][Full Text] [Related]
14.
Arantes LMRB; Cruvinel-Carloni A; de Carvalho AC; Sorroche BP; Carvalho AL; Scapulatempo-Neto C; Reis RM
Front Oncol; 2020; 10():1275. PubMed ID: 32850388
[No Abstract] [Full Text] [Related]
15. Diagnostic implications of TERT promoter mutation status in diffuse gliomas in a routine clinical setting.
Hewer E; Prebil N; Berezowska S; Gutt-Will M; Schucht P; Dettmer MS; Vassella E
Virchows Arch; 2017 Nov; 471(5):641-649. PubMed ID: 28823044
[TBL] [Abstract][Full Text] [Related]
16. The GABPB1 gene A/G polymorphism in Polish rowers.
Maciejewska-Karłowska A; Leońska-Duniec A; Cięszczyk P; Sawczuk M; Eider J; Ficek K; Sawczyn S
J Hum Kinet; 2012 Mar; 31():115-20. PubMed ID: 23486860
[TBL] [Abstract][Full Text] [Related]
17. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas.
Götze S; Wolter M; Reifenberger G; Müller O; Sievers S
Int J Cancer; 2010 Jun; 126(11):2584-93. PubMed ID: 19847810
[TBL] [Abstract][Full Text] [Related]
18. GABPB1 plays a cancer-promoting role in non-small cell lung cancer.
Wang T; Cao C; Fan Y; Xu J; Hua T; Ding J; Liu Z; Wang B; Lian J
Discov Oncol; 2024 Mar; 15(1):72. PubMed ID: 38466508
[TBL] [Abstract][Full Text] [Related]
19. HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis.
Ou R; Lv M; Liu X; Lv J; Zhao J; Zhao Y; Li X; Li W; Zhao L; Li J; Ren Y; Xu Y
FASEB J; 2020 Oct; 34(10):13211-13223. PubMed ID: 32844486
[TBL] [Abstract][Full Text] [Related]
20. A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.
Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Takajo T; Kirishima M; Hamada T; Matsuo K; Fujio S; Hanada T; Hosoyama H; Yonenaga M; Sakamoto A; Hiraki T; Tanimoto A; Yoshimoto K
Cancer Sci; 2020 Oct; 111(10):3902-3911. PubMed ID: 32748499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
